Asian Spectator

The Times Real Estate

.

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

  • Written by ACN Newswire - Press Releases

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

SYDNEY & SAN FRANCISCO, Mar 23, 2021 - (ACN Newswire) - TrialWire(TM), the most secure digital Patient Recruitment Platform for trial rescue, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost at any time, across one or all sites depending on recruitment needs.

TrialWire launches StudyBoost, the Clinical Trial Insurance Plan

TrialWire, the algorithm powered recruitment platform, launches a Clinical Trial recruitment 'Insurance' plan. (3/2021)

With more than 80% of clinical trials failing to recruit patients on time, 30% of research sites not able to meet enrollment goals, and 10% of sites not able to enroll any patients, StudyBoost offers peace of mind for Clinical Directors and their CROs.

StudyBoost was designed so that sponsors avoid a trial rescue crisis, saving valuable time and money. If a study needs extra patients, StudyBoost can start delivering instantly and at a significantly reduced cost to normal recruitment. There are no project fees and there is a 50% fee reduction for enrolled patient success.

StudyBoost is ideal for sponsors and CROs wanting to avoid extended recruitment stalls while they find a recruitment firm and process engagement documentation which can take weeks. Which means a study has a recruitment booster plan ready to action at any time recruitment slows.

The package is only available from the start of a study. StudyBoost is available via the TrialWire(TM) self-serve portal, at https://www.trial-wire.com/studyboost/.

About TrialWire(TM) - www.trial-wire.com

The TrialWire(TM) Platform is the most secure service, using advanced algorithms to find the right people who are online that might be suitable for studies listed on the Platform. They are invited into the Platform and taken through the AI-Match screener to determine an exact match to a study-site based or remote/virtual.

No account sign-up is required to find and apply for a study. And unlike all other digital recruitment firms, TrialWire(TM) does NOT keep patient details - no databases so no potential privacy breaches. Sponsors are not paying for database building where patients are sent to other studies.

The Platform ingests study data from approved trial registries like ClinicalTrials.Gov. It uses advanced algorithms, SEO, search marketing, social media, respected news sites, and wellness blogs and more to find patient/trial matches. The algorithms find people based on detailed demographic and location profiles.

Key to TrialWire(TM) success is that it finds motivated people who are online actively trying to find out more about their conditions. These people can be connected to a site in under 2 minutes, and demonstrate the highest retention rates. Find out more about TrialWire at: https://www.trial-wire.com.

Contact:Sydney NSW AUS HQ, +61 2 8218 2145Singapore APAC HQ, +65 3159 3427San Francisco USA HQ, +1 415 951 3228E: team@trial-wire.com, www.trial-wire.com

Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Program imbalan untuk melepas hiu dan pari: Antara risiko dan harapan untuk konservasi

An Indonesian fisher safely releases a critically endangered wedgefish. Francesca Page.Francesca Page, CC BY-NC-NDHiu dan pari termasuk dalam beberapa spesies paling terancam di dunia, terutama karena...

Ramai-ramai tiru Ghibli: Isu hak cipta dan data pribadi di balik tren AI

● Penggunaan AI untuk menghasilkan gambar berisiko melanggar hak cipta. ● Interaksi pengguna dengan AI berpotensi mengancam privasi.● Regulasi Indonesia belum cukup spesifik untuk me...

Beli produk ‘hijau’? Tetap waspada jebakan gimik ‘greenwashing’

● Tidak semua produk berlabel ‘eco’ atau ‘bio’ benar-benar ramah lingkungan. ● Praktik greenwashing masih sering terjadi di berbagai industri● Konsumen harus ...